These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32993263)

  • 1. [The value of Gd-EOB-DTPA-enhanced MRI in patients with major resection of liver cancer].
    Ye C; Ren SQ; AbuduHaibaier S; Guo X; Yuan M; Yuan CH; Xiu DR
    Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):765-769. PubMed ID: 32993263
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional remnant liver volumetry using Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) predicts post-hepatectomy liver failure in resection of more than one segment.
    Araki K; Harimoto N; Kubo N; Watanabe A; Igarashi T; Tsukagoshi M; Ishii N; Tsushima Y; Shirabe K
    HPB (Oxford); 2020 Feb; 22(2):318-327. PubMed ID: 31477460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of Gd-EOB-DTPA -enhanced magnetic resonance imaging for post-hepatectomy liver failure: a systematic review and meta-analysis.
    Ding C; Jia J; Bai G; Zhou W; Shan W
    Acta Radiol; 2023 Apr; 64(4):1347-1356. PubMed ID: 36303435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic uptake index in the hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine penta acetic acid-enhanced magnetic resonance imaging estimates functional liver reserve and predicts post-hepatectomy liver failure.
    Donadon M; Lanza E; Branciforte B; Muglia R; Lisi C; Pedicini V; Poretti D; Famularo S; Balzarini L; Torzilli G
    Surgery; 2020 Sep; 168(3):419-425. PubMed ID: 32600880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E; Long W; Luo L; Hu M; Huang L; Chen X
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting post-hepatectomy liver failure by combined volumetric, functional MR image and laboratory analysis.
    Chuang YH; Ou HY; Lazo MZ; Chen CL; Chen MH; Weng CC; Cheng YF
    Liver Int; 2018 May; 38(5):868-874. PubMed ID: 28987012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
    World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Remnant Liver Function Evaluation Using a Routine Clinical Dynamic Gd-EOB-DTPA-Enhanced MRI Protocol in Patients with Hepatocellular Carcinoma.
    Wang Y; Zhang L; Ning J; Zhang X; Li X; Zhang L; Chen G; Zhao X; Wang X; Yang S; Yuan C; Dong J; Chen H
    Ann Surg Oncol; 2021 Jul; 28(7):3672-3682. PubMed ID: 33230746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI.
    Theilig D; Steffen I; Malinowski M; Stockmann M; Seehofer D; Pratschke J; Hamm B; Denecke T; Geisel D
    Eur Radiol; 2019 Nov; 29(11):5861-5872. PubMed ID: 30899977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of post-hepatectomy liver failure using gadoxetic acid-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein invasion.
    Tsujita Y; Sofue K; Komatsu S; Yamaguchi T; Ueshima E; Ueno Y; Kanda T; Okada T; Nogami M; Yamaguchi M; Tsurusaki M; Hori M; Fukumoto T; Murakami T
    Eur J Radiol; 2020 Sep; 130():109189. PubMed ID: 32784077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of gadoxetate disodium-enhanced MR imaging for predicting posthepatectomy liver failure after major hepatic resection: a preliminary study.
    Cho SH; Kang UR; Kim JD; Han YS; Choi DL
    Eur J Radiol; 2011 Nov; 80(2):e195-200. PubMed ID: 21908121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular uptake index obtained with gadoxetate disodium-enhanced magnetic resonance imaging in the assessment future liver remnant function after major hepatectomy for biliary malignancy.
    Notake T; Shimizu A; Kubota K; Ikehara T; Hayashi H; Yasukawa K; Kobayashi A; Yamada A; Fujinaga Y; Soejima Y
    BJS Open; 2021 Jul; 5(4):. PubMed ID: 34254117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
    Chen CY; Chen J; Xia CC; Huang ZX; Song B
    J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
    Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C
    Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
    Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
    PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-fat and liver-function indices derived from Gd-EOB-DTPA-enhanced liver MRI for prediction of future liver remnant growth after portal vein occlusion.
    Barth BK; Fischer MA; Kambakamba P; Lesurtel M; Reiner CS
    Eur J Radiol; 2016 Apr; 85(4):843-9. PubMed ID: 26971433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
    Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
    Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.